You Searched For "remdesivir coronavirus patient" and got 18 results
Sort By:
5 mins read
Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study
Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…
1 min read
How remdesivir drug can save lives in nations with lower hospital capacity
Amid news that the US has bought up virtually the entire global supply of remdesivir, a new study o…
2 mins read
Remdesivir linked to reduced risk of death in severe Covid-19 patients
This is an important finding that requires confirmation in prospective clinical trials, Gilead s…
2 mins read
Gilead's remdesivir just got the first FDA approval to be used as a treatment for coronavirus patients
Gilead Sciences just received approval from the US Food and Drug Administration to use its antivira…
Allana Akhtar
3 mins read
The WHO will not recommend remdesivir for COVID-19 patients, since it doesn't seem to boost their chances of survival
In a statement on Thursday, the World Health Organization said it will not recommend remdesivir bec…
Susie Neilson
1 min read
US FDA approves emergency use of Remdesivir for COVID-19 patients
The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the e…
2 mins read
Gilead tanks 9% on report its coronavirus drug doesn't help patients
The report contained "inappropriate characterizations," Gilead said, adding that low enrollment led…
Ben Winck
4 mins read
Remdesivir proved to be the first useful tool we have in treating COVID-19 patients. Now, the US government wants to find out more about how it could be supercharged with other drugs.
The National Institutes of Health announced a massive new study Friday to test 3 immune modulators …
Andrew Dunn
3 mins read
The $96 billion biotech Gilead will start testing a new version of the first effective coronavirus treatment, and it could make remdesivir available to vastly more patients
If the inhaled version of remdesivir works, it "could have significant implications in helping to s…
Andrew Dunn
3 mins read
US health authorities are reportedly preparing to allow emergency use of Gilead's antiviral remdesivir to treat coronavirus patients, following positive study results
FDA is reportedly preparing to allow emergency use of remdesivir as soon as today. The treatment he…
Andrew Dunn
3 mins read
Gilead has yet to set a price for the coronavirus treatment remdesivir, but an influential drug pricing watchdog says it could be worth up to $4,500 per patient
The nonprofit group often finds drugs to be overpriced. For the first potential COVID-19 drug, it s…
Andrew Dunn
2 mins read
Remdesivir is an effective coronavirus treatment claims study
The news about remdesivir, the investigational anti-viral drug that has shown early promise in the …
6 mins read
Drugs used to combat COVID-19 — what works and what doesn’t
(Disclaimer: This should not be considered medical advice. Please check with your doctor before tak…
4 mins read
Cipla, Zydus Cadila, Jubilant Life and Dr Reddy’s shares gain after FDA approves Remdesivir for treating COVID-19 patients
The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained dur…
3 mins read
The curious case of Remdesivir — the coronavirus ‘miracle drug’ may be overhyped, suggests Lancet study
Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases (NIAID)…
2 mins read
Faulty pulse oximeter readings delayed life-saving treatments for Black COVID-19 patients, research finds
Pulse oximeters that measure blood oxygen levels gave inaccurate readings for Black patients, delay…
Allana Akhtar
2 mins read
What to know about Trump's coronavirus treatment regimen
These are Business Insider's biggest healthcare stories for October 5.
Lydia Ramsey Pflanzer
2 mins read
Cipla signs licensing agreement with Gilead to manufacture and sell antiviral drug remdesivir
Leading pharmaceutical company Cipla on Wednesday announced it has signed a non-exclusive licensing…